TW200716545A - Indole derivatives having anti-tumor activity - Google Patents

Indole derivatives having anti-tumor activity

Info

Publication number
TW200716545A
TW200716545A TW095118475A TW95118475A TW200716545A TW 200716545 A TW200716545 A TW 200716545A TW 095118475 A TW095118475 A TW 095118475A TW 95118475 A TW95118475 A TW 95118475A TW 200716545 A TW200716545 A TW 200716545A
Authority
TW
Taiwan
Prior art keywords
indole derivatives
tumor activity
antitumour
tumours
activity
Prior art date
Application number
TW095118475A
Other languages
English (en)
Chinese (zh)
Inventor
Claudio Pisano
Gianfranco Battistuzzi
Marzo Maria Di
Giuseppe Giannini
Mauro Marzi
Loredana Vesci
Franco Zunino
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of TW200716545A publication Critical patent/TW200716545A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
TW095118475A 2005-06-10 2006-05-24 Indole derivatives having anti-tumor activity TW200716545A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05012562 2005-06-10

Publications (1)

Publication Number Publication Date
TW200716545A true TW200716545A (en) 2007-05-01

Family

ID=35062959

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095118475A TW200716545A (en) 2005-06-10 2006-05-24 Indole derivatives having anti-tumor activity

Country Status (13)

Country Link
US (1) US8053460B2 (https=)
EP (1) EP1891007A1 (https=)
JP (1) JP2008542428A (https=)
KR (1) KR20080029967A (https=)
CN (1) CN101193861A (https=)
AR (1) AR053891A1 (https=)
AU (1) AU2006256771A1 (https=)
BR (1) BRPI0612542A2 (https=)
CA (1) CA2607337A1 (https=)
EA (1) EA013542B1 (https=)
MX (1) MX2007015274A (https=)
TW (1) TW200716545A (https=)
WO (1) WO2006131484A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010086646A1 (en) * 2009-01-28 2010-08-05 Karus Therapeutics Limited Scriptaid isosteres and their use in therapy
TWI429628B (zh) * 2010-03-29 2014-03-11 Univ Taipei Medical 吲哚基或吲哚啉基羥肟酸化合物
IN2015DN03235A (https=) 2012-11-07 2015-10-02 Karus Therapeutics Ltd
PT2994465T (pt) 2013-05-10 2018-10-25 Karus Therapeutics Ltd Novos inibidores de histona desacetilase
GB201419264D0 (en) 2014-10-29 2014-12-10 Karus Therapeutics Ltd Compounds
GB201419228D0 (en) 2014-10-29 2014-12-10 Karus Therapeutics Ltd Compounds
RU2633266C2 (ru) * 2015-07-02 2017-10-11 Рауф Ашрафович Ашрафов Способ моделирования карциноидного синдрома
CN105367479A (zh) * 2015-11-16 2016-03-02 青岛大学 一种组蛋白去乙酰酶抑制剂2-(1-(4-氯苯甲酰基)-5-甲氧基-2-甲基-1氢-吲哚-3-基-n-(2-(羟氨基)-2-酮乙基)乙酰胺及其制备方法和应用
CN109928909A (zh) * 2019-04-02 2019-06-25 南华大学 具有抗抑郁活性化合物及其制备方法
CN120136763B (zh) * 2025-03-13 2025-10-10 遵义医科大学 一种c-3苄基化吲哚类化合物、制备方法及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0887348A1 (en) * 1997-06-25 1998-12-30 Boehringer Mannheim Italia S.p.A. Bis-Indole derivatives having antimetastatic activity, a process for their preparation and pharmaceutical compositions containing them
IT1317925B1 (it) * 2000-11-03 2003-07-15 Sigma Tau Ind Farmaceuti Bis-eterocicli ad attivita' antitumorale e chemosensibilizzante.
WO2003032982A1 (en) * 2001-10-19 2003-04-24 Transtech Pharma, Inc. Bis-heteroaryl alkanes as therapeutic agents
JP4790594B2 (ja) * 2003-02-25 2011-10-12 トポターゲット ユーケー リミテッド Ｈｄａｃインヒビターとしての、二環式ヘテロアリール基を含むヒドロキサム酸化合物

Also Published As

Publication number Publication date
EA013542B1 (ru) 2010-06-30
CA2607337A1 (en) 2006-12-14
US20080207729A1 (en) 2008-08-28
US8053460B2 (en) 2011-11-08
AR053891A1 (es) 2007-05-23
AU2006256771A1 (en) 2006-12-14
JP2008542428A (ja) 2008-11-27
WO2006131484A1 (en) 2006-12-14
KR20080029967A (ko) 2008-04-03
CN101193861A (zh) 2008-06-04
EP1891007A1 (en) 2008-02-27
EA200702672A1 (ru) 2008-04-28
BRPI0612542A2 (pt) 2010-11-23
MX2007015274A (es) 2008-02-22

Similar Documents

Publication Publication Date Title
IL260127B (en) mek inhibitors and methods of using them
TNSN07322A1 (en) Pyrimidine derivatives for treatment of hyperproliferative disorders
MX2009002735A (es) Derivados de oxindol como agentes anticancerigenos.
MX2010003868A (es) Cis-imidazolinas quirales.
TW200610531A (en) Phthalazine derivatives as PARP inhibitors
TW200508214A (en) Novel compounds
MX2010003156A (es) Derivados de aril amida substituida con tetrazol y usos de los mismos.
TW200801003A (en) Novel compounds
EA200801428A1 (ru) Производные пиридиазинона для лечения опухолей
TW200745004A (en) Novel compounds, their preparation and use
CA2672094C (en) Methods and apparatus for identifying subject matter in view data
TW200736229A (en) Substituted 1H-benzimidazole-4-carboxamides are potent PARP inhibitors
MY152018A (en) Indole derivatives as anticancer agents
TW200738659A (en) Novel compounds
TW200716545A (en) Indole derivatives having anti-tumor activity
MX2008001538A (es) Aril piridinas y metodos para su uso.
MY157425A (en) Substituted oxindole derivatives and the use thereof for the treatment of vasopressin-dependent illnesses
TW200738649A (en) Calcilytic compounds
IL191670A0 (en) Compounds for the inhibition of apoptosis
TW200738625A (en) 3-Amino-1-arylpropyl indoles and aza-substituted indoles
IL173809A0 (en) Imidazopyridine derivatives and pharmaceutical compositions containing the same
GB0305928D0 (en) Organic compounds
MX2007007496A (es) Derivados de indol con actividad antitumoral.
TW200718691A (en) Cinnamic and phenylpropiolic acid derivatives useful as anti-tumour agents
TW200621270A (en) Novel use of nanogold for manufacturing medicaments for inhibiting metastasis of malignant tumors and growth of leukemic cells, and pharmaceutical compositions for inhibiting metastasis of malignant tumors and for treating leukemia comprising nanogold